Abbott Laboratories (FRA:ABL) Long-Term Debt : €11,570 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Long-Term Debt?

Abbott Laboratories's Long-Term Debt for the quarter that ended in Mar. 2024 was €11,570 Mil.

Abbott Laboratories's quarterly Long-Term Debt declined from Sep. 2023 (€13,565 Mil) to Dec. 2023 (€12,470 Mil) and declined from Dec. 2023 (€12,470 Mil) to Mar. 2024 (€11,570 Mil).

Abbott Laboratories's annual Long-Term Debt declined from Dec. 2021 (€15,307 Mil) to Dec. 2022 (€13,709 Mil) and declined from Dec. 2022 (€13,709 Mil) to Dec. 2023 (€12,470 Mil).

Abbott Laboratories Long-Term Debt Historical Data

The historical data trend for Abbott Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Long-Term Debt Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

14,994.90

15,229.19

15,306.96

13,708.77

12,470.28

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															13,650.41	13,440.73	13,564.95	12,470.28	11,569.92

Abbott Laboratories (FRA:ABL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Abbott Laboratories Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (FRA:ABL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (FRA:ABL) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.